Couverture de GEN Podcasts

GEN Podcasts

GEN Podcasts

De : Genetic Engineering & Biotechnology News (GEN)
Écouter gratuitement

À propos de ce contenu audio

Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.

GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies.

Hosted on Acast. See acast.com/privacy for more information.

Genetic Engineering & Biotechnology News (GEN) Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera

      The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera
      Apr 11 2025

      Sponsored by Seqera


      As data volumes in life sciences continue to grow, bioinformaticians and researchers are more dependent than ever on solutions that help them streamline workflows, manage data, and scale their research. In this timely podcast, Evan Floden, CEO and co-founder of Seqera, shares how his company is addressing these needs through Nextflow—the open-source orchestrator for scalable, reproducible, and portable scientific workflows—and Seqera Platform, a unified solution for the entire scientific data lifecycle. He also discusses how Seqera has become a widely adopted solution, trusted by 13 of the top 20 pharmaceutical companies, empowering breakthroughs in drug discovery, genomics, clinical research, and.beyond.

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      18 min
    • Smart Vector Design for Improved Cell and Gene Therapies

      Smart Vector Design for Improved Cell and Gene Therapies
      Apr 8 2025
      In the episode, we’re talking about vector design and delivery for gene therapies. The field of cell and gene therapies is advancing, but there are still challenges with delivery vectors that need to be addressed. In this podcast, experts discuss current immunogenicity hurdles, evolving DMPK strategies, and a new generation of bioanalytical tools that are contributing to the progress in the field.

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      1 h et 1 min
    • From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing

      From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing
      Apr 8 2025
      There are an estimated 6,000 Mendelian diseases, most of which still lack cures. Gene editing is an essential technology for studies aimed at generating data about disease-causing gene mutations and networks in order to identify optimal therapeutic targets. In this episode, experts will discuss applications of gene editing to improve scientists understanding of the relationship between variant and disease in functional genomics studies. They will also talk about the Dharmacon product suite which is designed for CRISPR-based targeted editing in a wide range of cells.

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      59 min
    Aucun commentaire pour le moment